News Medical on MSN10 小时
Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers ...
Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's ...
The Cool Down on MSN7 小时
Researchers make alarming new discovery while investigating side effects of cigarettes ...
Scientists recently investigated what happens when human immune cells are exposed to the microplastics found in cigarette ...
The American Journal of Managed Care15 小时
Mirikizumab Demonstrates Superior Maintenance Efficacy in UC Treatment
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Coya reports promising Alzheimer's treatment study results
HOUSTON - Coya Therapeutics, Inc. (NASDAQ: COYA), a $109.1 million market cap biotechnology company focusing on regulatory T ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Harvard Scientists Uncover How Gut Bacteria Fuel Inflammation and Depression
Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.
labiotech16 小时
Top biotech deals of January 2025
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
AnaptysBio’s (ANAB) Neutral Rating Reiterated at HC Wainwright
AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $19.00 ...